GlassScriptPhysician profile
Ali N Dana
NPI 1063620300
$6,900.43
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.85 · 2020: $393 · 2021: $3,174 · 2022: $3,285 · 2023: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,242.93 | 2020-2022 | |
| Genzyme Corporation | $529.22 | 2020-2022 | |
| Allergan, INC. | $450.33 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $360.15 | 2020-2022 | |
| Amgen INC. | $356.66 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $351.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $348.01 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $292.98 | 2020-2022 | |
| Incyte Corporation | $292.65 | 2021-2022 | |
| Lilly USA, LLC | $255.40 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $203.91 | 2021-2022 | |
| Almirall LLC | $180.00 | 2021 | |
| Janssen Biotech, INC. | $163.32 | 2021-2022 | |
| Ucb, INC. | $159.11 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $146.99 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $112.66 | 2020 | |
| Journey Medical Corporation | $110.01 | 2022 | |
| Pfizer INC. | $66.79 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $50.43 | 2020-2021 | |
| Biofrontera INC. | $45.15 | 2020-2022 | |
| Leo Pharma INC. | $43.94 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $30.84 | 2021 | |
| Arcutis Biotherapeutics, INC. | $25.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $23.85 | 2019 | |
| Genentech USA, INC. | $19.98 | 2021 | |
| Kyowa Kirin, INC. | $14.37 | 2020 | |
| Dermira, INC. | $12.28 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $11.85 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Dana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.